NASDAQ
Aeolus Pharmaceuticals, Inc. (AOLS) has a fcf yield of -11.01% as of Friday, May 29, 2026. This represents a 116.61% decrease compared to its 12-month average of -5.08%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.